Cardiovascular comorbidity and death from COVID-19: Prevalence and differential characteristics.
作者信息
Playán-Escribano Julia, Gómez-Álvarez Zaira, Romero-Delgado Teresa, Pérez-García Carlos Nicolás, Enríquez-Vázquez Daniel, Vilacosta Isidre
机构信息
Hospital Clínico San Carlos, Profesor Martín Lagos s/n, 28040 Madrid, Spain.
出版信息
Cardiol J. 2021;28(2):339-341. doi: 10.5603/CJ.a2021.0023. Epub 2021 Feb 26.
Abstract
摘要
相似文献
1
Cardiovascular comorbidity and death from COVID-19: Prevalence and differential characteristics.心血管合并症与 COVID-19 死亡：患病率及差异特征。
Cardiol J. 2021;28(2):339-341. doi: 10.5603/CJ.a2021.0023. Epub 2021 Feb 26.
2
COVID-19 with Cardiovascular Disease: Can It Help Predict Prognosis?患有心血管疾病的COVID-19：它能帮助预测预后吗？
Heart Surg Forum. 2020 Nov 30;23(6):E895-E896. doi: 10.1532/hsf.3301.
3
COVID-19 and cardiovascular disease: what have we learned?2019冠状病毒病与心血管疾病：我们学到了什么？
Swiss Med Wkly. 2020 Dec 31;150:w20452. doi: 10.4414/smw.2020.20452. eCollection 2020 Dec 14.
4
Sex-Biased Vulnerability of the Heart to COVID-19.心脏对新冠病毒的性别差异易感性
Mayo Clin Proc. 2020 Nov;95(11):2332-2335. doi: 10.1016/j.mayocp.2020.09.017. Epub 2020 Sep 18.
5
Competing risk largely explains the drop in admissions for acute cardiovascular disease during the COVID-19 pandemic. Response.竞争风险在很大程度上解释了 COVID-19 大流行期间急性心血管疾病入院人数的下降。回应。
Rev Esp Cardiol (Engl Ed). 2020 Dec;73(12):1085. doi: 10.1016/j.rec.2020.08.014. Epub 2020 Oct 7.
6
Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case-Control Study.间质性肺疾病合并新型冠状病毒肺炎患者死亡几率增加：一项病例对照研究
Am J Respir Crit Care Med. 2020 Dec 15;202(12):1710-1713. doi: 10.1164/rccm.202006-2441LE.
7
Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak.在新冠疫情期间取消择期心脏介入手术的后果。
Catheter Cardiovasc Interv. 2021 Apr 1;97(5):927-937. doi: 10.1002/ccd.29433. Epub 2020 Dec 17.
8
Impact of Focused Echocardiography on Scan Time and Diagnostic Quality in Patients with COVID-19.聚焦超声心动图对COVID-19患者扫描时间和诊断质量的影响。
J Am Soc Echocardiogr. 2020 Nov;33(11):1415-1416. doi: 10.1016/j.echo.2020.08.007. Epub 2020 Aug 7.
9
Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering From Coronavirus Disease in Wuhan, China.中国武汉 244 例心血管病患者感染冠状病毒疾病的临床特征和预后。
J Am Heart Assoc. 2020 Oct 20;9(19):e016796. doi: 10.1161/JAHA.120.016796. Epub 2020 Aug 14.
10
Contrast Echocardiography in VV-ECMO-Dependent Patients with COVID-19.新冠病毒病依赖静脉-静脉体外膜肺氧合患者的对比超声心动图
J Am Soc Echocardiogr. 2020 Nov;33(11):1419-1420. doi: 10.1016/j.echo.2020.07.012. Epub 2020 Jul 17.
引用本文的文献
1
The Influence of COVID-19 on Out-Hospital Cardiac Arrest Survival Outcomes: An Updated Systematic Review and Meta-Analysis.2019冠状病毒病对院外心脏骤停生存结局的影响：一项更新的系统评价和荟萃分析
J Clin Med. 2021 Nov 27;10(23):5573. doi: 10.3390/jcm10235573.
本文引用的文献
1
Impaired microcirculation function in COVID-19 and implications for potential therapies.新型冠状病毒肺炎中微循环功能受损及其对潜在治疗的意义。
Cardiol J. 2020;27(5):485-488. doi: 10.5603/CJ.2020.0154.
2
Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients.心肌损伤的确定可改善 COVID-19 患者的风险分层并预测其死亡率。
Cardiol J. 2020;27(5):489-496. doi: 10.5603/CJ.a2020.0089. Epub 2020 Jun 26.
3
COVID-19 - Toward a comprehensive understanding of the disease.COVID-19 - 对该疾病的全面认识。
Cardiol J. 2020;27(2):99-114. doi: 10.5603/CJ.a2020.0065. Epub 2020 May 7.
4
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
5
Laboratory abnormalities in patients with COVID-2019 infection.2019冠状病毒病感染患者的实验室异常情况。
Clin Chem Lab Med. 2020 Jun 25;58(7):1131-1134. doi: 10.1515/cclm-2020-0198.
6
Troponin Testing for Assessing Sepsis-Induced Myocardial Dysfunction in Patients with Septic Shock.肌钙蛋白检测在评估感染性休克患者脓毒症诱导的心肌功能障碍中的应用
J Clin Med. 2019 Feb 12;8(2):239. doi: 10.3390/jcm8020239.
7
BTS guidelines for the management of community acquired pneumonia in adults: update 2009.英国胸科学会成人社区获得性肺炎管理指南：2009年更新版
Thorax. 2009 Oct;64 Suppl 3:iii1-55. doi: 10.1136/thx.2009.121434.
Zotero 插件